pritelivir diminue significativement la fréquence de la présence d'HSV au niveau de la muqueuse génitale et la quantité de virus détecté ,
12 épisodes de récurrences dans le groupe recevant le placebo 18 épisodes dans le groupe recevant 5mg/j 12 épisodes dans le groupe recevant 25mg/j 3 épisodes dans le groupe recevant 75mg ,
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry, FEBS Journal, vol.280, issue.24, pp.7228-7236, 2009. ,
DOI : 10.1111/j.1742-4658.2009.07402.x
Herpes simplex viruses, Encyclopedia of virology, pp.587-626, 1994. ,
Aspects of herpes simplex virus: a clinical review, Journal of Family Planning and Reproductive Health Care, vol.35, issue.4, pp.237-242, 2009. ,
DOI : 10.1783/147118909789587376
Manifestations dermatologiques des maladies infectieuses, métaboliques et toxiques, 2008. ,
DOI : 10.1007/978-2-287-48494-0
Helicase???primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections, Future Medicinal Chemistry, vol.6, issue.1, pp.45-55, 2014. ,
DOI : 10.4155/fmc.13.192
Infections ?? cytom??galovirus humain en transplantation??: diagnostic virologique et traitement antiviral, Journal des Anti-infectieux, vol.13, issue.4, pp.238-245, 2011. ,
DOI : 10.1016/j.antinf.2011.10.002
The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells, Reviews in Medical Virology, vol.235, issue.5, pp.305-319, 2000. ,
DOI : 10.1002/1099-1654(200009/10)10:5<305::AID-RMV286>3.0.CO;2-T
ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2, Journal of Antimicrobial Chemotherapy, vol.65, issue.8, pp.1733-1741, 2010. ,
DOI : 10.1093/jac/dkq198
Characterization of virus strains resistant to the herpes virus helicase???primase inhibitor ASP2151 (Amenamevir), Biochemical Pharmacology, vol.84, issue.4, pp.459-467, 2012. ,
DOI : 10.1016/j.bcp.2012.05.020
Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus, Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicellazoster virus, pp.154-160, 2013. ,
DOI : 10.1016/j.antiviral.2012.12.006
Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications, Annals of Internal Medicine, vol.98, issue.6, pp.958-972, 1983. ,
DOI : 10.7326/0003-4819-98-6-958
Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with Acyclovir, New England Journal of Medicine, vol.306, issue.6, pp.343-346, 1982. ,
DOI : 10.1056/NEJM198202113060606
Surveillance Network for Herpes Simplex Virus Resistance to Antiviral Drugs: 3-Year Follow-Up, Journal of Clinical Microbiology, vol.42, issue.1, pp.242-249, 2004. ,
DOI : 10.1128/JCM.42.1.242-249.2004
URL : https://hal.archives-ouvertes.fr/hal-00123398
Vaccination antiherpès simplex virus : perspectives, La Revue de medicine Interne, pp.16-21, 2007. ,
DOI : 10.1016/j.revmed.2006.09.022
Les virus transmissibles de la mère à l'enfant, pp.191-276, 1999. ,
Huiles essentielles Guide d'utilisation, éditions Ravintsara, 2010. ,
Efficacy of ASP2151, a helicase???primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo, Antiviral Research, vol.93, issue.2, pp.301-304, 2012. ,
DOI : 10.1016/j.antiviral.2011.11.015
Les maladies sexuellement transmissibles, 2009. ,
Les plantes qui soignent : le cyprès fait disparaitre les boutons de fièvre, www.lepoint.fr consulté le, 2014. ,
Herpesviruses remodel host membranes for virus egress, Nature Reviews Microbiology, vol.86, issue.5, pp.382-394, 2011. ,
DOI : 10.1038/nrmicro2559
Effect of ASP2151, a Herpesvirus Helicase-Primase Inhibitor, Guinea Pig Model of Genital Herpes, vol.16, pp.7210-7223, 2011. ,
Susceptibility of Herpes Simplex Virus Isolated from Genital Herpes Lesions to ASP2151, a Novel Helicase-Primase Inhibitor, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3587-3591, 2012. ,
DOI : 10.1128/AAC.00133-12
Sexually transmitted infections in alleged sexual abuse of children and adolescents, Journal of Paediatrics and Child Health, vol.135, issue.6, pp.434-440, 2006. ,
DOI : 10.1016/j.chiabu.2004.10.015
Herpes Simplex Virus Latency-Associated Transcript Gene Function, Journal of Neurovirology, vol.9, issue.3, pp.434-440, 2003. ,
DOI : 10.1080/13550280390200994
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.321.8511
Neonatal Herpes Simplex Infection, Clinical Microbiology Reviews, vol.17, issue.1, pp.1-13, 2004. ,
DOI : 10.1128/CMR.17.1.1-13.2004
Module « santé et environnement Maladies transmissibles ,
Biology and molecular aspects of herpes simplex and varicella-zoster virus infections, Ophtalmology, pp.781-799, 1992. ,
Oral viral infections, Clinics in Dermatology, vol.18, issue.5, pp.619-628, 2000. ,
DOI : 10.1016/S0738-081X(00)00138-3
Pharmacokinetics of valaciclovir, Journal of Antimicrobial Chemotherapy, vol.53, pp.899-901, 2004. ,
Seroprevalence of HSV-1 and HSV-2 infection in the general French population, Sexually Transmitted Infections, vol.78, issue.3, pp.201-203, 2002. ,
DOI : 10.1136/sti.78.3.201
Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study, Journal of the European Academy of Dermatology and Venereology, vol.3, issue.10, pp.1398-1403, 2007. ,
DOI : 10.1001/archfami.4.3.228
Virologie médicale, Presses universitaires de Lyon, pp.485-543, 2002. ,
Anabible infection herpès, www.anabible.webethan consulté le, 2013. ,
Le phenomene de latence chez les herpes virus, M??decine et Maladies Infectieuses, vol.17, issue.11, pp.604-608, 1987. ,
DOI : 10.1016/S0399-077X(87)80111-7
The family herpesviridae : a brief introduction,Field'sVirology, pp.2479-2499, 2007. ,
Dermatite atopique de l'enfant, 1999. ,
Herpes simplex viruses, Fields' Virology, pp.2501-2601, 2007. ,
Antiviral therapy of herpes simplex, International Journal of Antimicrobial Agents, vol.16, issue.2, pp.157-159, 2000. ,
DOI : 10.1016/S0924-8579(00)00233-8
Herpes simplex virus: receptors and ligands for cell entry, Cellular Microbiology, vol.71, issue.5, pp.401-410, 2004. ,
DOI : 10.1128/JVI.77.17.9695-9699.2003
Herpes Simplex Virus Infection as a Cause of Benign Recurrent Lymphocytic Meningitis, Annals of Internal Medicine, vol.121, issue.5, pp.334-338, 1994. ,
DOI : 10.7326/0003-4819-121-5-199409010-00004
A propos d'un cas de paralysie des dilatateurs de la glotte associé à une primo-infection herpétique, Annales françaises d'oto-rhino-laryngologie et de pathologie cervico, pp.309-311, 2012. ,
The Desk Encyclopedia of Microbiology, pp.107-112, 2009. ,
Mucocutaneous manifestations of viral diseases in children, Clinics in Dermatology, vol.20, issue.1, pp.67-73, 2002. ,
DOI : 10.1016/S0738-081X(01)00233-4
Herpes Simplex Viruses, Clinical Infectious Diseases, vol.26, issue.3, pp.541-555, 1998. ,
DOI : 10.1086/514600